A Study Of Spinal Cord Stimulation For Treatment Of Chronic Regional Pain

Overview

About this study

The purpose of this study is to identify SCS parameters that affect neurophysiology related to leg pain.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Greater than 21 years old

  • American Spinal Injury Association Impairment Scale A-D, to encompass a representational spectrum of autonomic dysfunction after spinal cord injury

  • A diagnosis or history of chronic lower body pain

  • Neurological level of injury above T10, as defined by the International Standards for Neurological Classification of Spinal Cord Injury. Incorporating level of injury over this broad range to capture the spectrum of autonomic dysfunction. Individuals with injuries below T10 will not be included to ensure transcutaneous spinal cord stimulation does not occur over the injury/glial scar, where it may have altered properties.

  • Time since injury of greater than six months, given early changes in spinal cord connectivity and recovery prior to this.

  • Both individuals with and without currently implanted epidural spinal cord stimulators will be enrolled

Exclusion Criteria: 

  • Severe cardiopulmonary dysfunction

  • Untreated active depression

  • Frequent hypotension or uncontrolled hypertension

  • Significant cognitive impairment

  • Positive pregnancy test

  • Enrollment in another interventional clinical trial

  •   Incarceration or pending legal action

  • Any condition that may compromise protocol adherence, patient safety, or data validity

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 008/11/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Anders Asp, Ph.D.

Open for enrollment

Contact information:

Candee Mills M.S.

MCSCICARE@mayo.edu

More information

Publications

Publications are currently not available